Evaluating Perioperative Intravenous Lidocaine Infusion for Enhanced Recovery After Major Non-Cardiac Surgery
Led by Vanderbilt University Medical Center · Updated on 2026-11-02
2290
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the use of intravenous IV lidocaine as part of the Enhanced Recovery After Surgery ERAS program for patients undergoing major non-cardiac surgery. This randomized, placebo-controlled trial aims to determine if IV lidocaine can reduce hospital length of stay adjusted for case mix CARLOS, decrease inpatient opioid use, lower pain scores, and improve surgical outcomes. The study also monitors side effects such as vision changes, tinnitus, sedation, and adverse events leading to early treatment stop.
Participants are randomly assigned to receive either a lidocaine infusion or a placebo during surgery and for up to 48 hours afterward. The lidocaine group receives a 1.5 mgkg bolus of 0.8% lidocaine hydrochloride in dextrose 5% in water D5W at induction, followed by continuous IV infusion intraoperatively and weight-based dosing postoperatively. The placebo group receives an equivalent volume of D5W with matching infusion timing.
During the study, participants hospital stays, opioid consumption, pain levels, and surgical outcomes are closely monitored. Pain scores are recorded at multiple time points after surgery, and side effects are tracked throughout treatment. The primary outcomes include measuring hospital length of stay and total opioid use up to 72 hours. Participants are followed until hospital discharge and up to 30 days post-discharge to assess recovery and complications.
CONDITIONS
Brief Title
The Impact of Perioperative Lidocaine Infusions on Enhanced Recovery After Non-Cardiac Surgery
Research Team
D
Danial Shams, MD
M
Miklos Kertai, MD, MMHC, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
Factors
Intravenous lidocaine infusion
Placebo infusion
What the option is
An investigational regimen of perioperative intravenous lidocaine infusion, started with a bolus at induction and continued intraoperatively with weight‑based dosing postoperatively up to 48 hours
A placebo infusion of D5W with matched bolus and continuous infusion equivalent in volume and rate
Role in the trial
Investigational treatment arm
Control comparator arm
Primary purpose
To assess whether perioperative lidocaine infusion reduces opioid consumption and improves recovery within Enhanced Recovery After Surgery protocols
Control to isolate the effect of intravenous lidocaine on postoperative opioid use and recovery
How it is administered
Lidocaine bolus at induction followed by continuous intraoperative infusion and weight‑based postoperative infusion up to 48 hours
Volume‑matched D5W bolus and continuous infusion administered on the same schedule
Evidence beyond this trial
Meta‑analyses of randomized trials show perioperative IV lidocaine reduces postoperative pain and opioid use, shortens hospital stay, and may reduce chronic postsurgical pain at 3 months
Standard care placebo has no active analgesic effect; serves as comparator in studies
Important risks
IV lidocaine carries risk of systemic toxicity and must be administered with careful dosing and monitoring
No drug‑related risk; placebo infusion of D5W is inert
Limitations
Efficacy and safety depend on precise infusion protocols and monitoring; effects vary by surgery type and comorbidities
Placebo provides no direct clinical benefit; intended for comparison only
Observed patient impact
Improvements in postoperative pain, opioid reduction, and functional recovery have been observed in prior RCTs
Placebo does not impact pain or recovery outcomes; serves as control
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 18Years +
All Genders
Eligibility Criteria
You may qualify if you...
Age greater than or equal to 18
American Society of Anesthesiologists (ASA) class I-IV
Scheduled for major elective, non-cardiac surgery on colorectal, emergency general surgery, urology, ventral hernia, surgical oncology, or spine services on a weekday
First surgery during the study period if multiple surgeries occur
You will not qualify if you...
ASA class greater than IV
Emergency procedures
Allergy or contraindication to lidocaine
Patient refusal to participate
Unable or unwilling to receive a regional nerve block
Receiving an epidural due to standard care
Direct transfer from operating room to ICU with endotracheal tube in place
Treating team deems patient ineligible before study drug administration
Same day surgery
Pregnancy (all female participants of child-bearing age will have a pregnancy test on surgery day)
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - Up to 48 hours
Participants receive either intravenous lidocaine or placebo infusions during surgery and for up to 48 hours after. Dosage is adjusted based on weight and timing during and after the operation.
Continuous infusion during surgery and postoperative period
Follow-up
Duration - Up to 30 days post-discharge
Participants are monitored for pain levels, opioid use, surgical recovery, and side effects until hospital discharge and up to 30 days after surgery.
Pain scores recorded at several time points; assessments of recovery outcomes
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Comparing 3-Needle and 5-Needle Genicular Nerve Blocks for Pain and Quality of Life in Knee Osteoarthritis
Study of Mixed Reality Cognitive Distraction Therapy for Adults with Chronic Pain
A Multicenter, Randomized, Single-Blind Clinical Trial
Study Comparing Combined Manual Therapy and Vagus Nerve Stimulation to Manual Therapy Alone for Adults with Myogenic Temporomandibular Joint Disorders
Phase 1 Study of TT5 to Evaluate Safety and Pharmacokinetics in Healthy Adults and Surgical Patients Using Single and Multiple Intravenous Doses
Testing the Grasp Handheld Device to Reduce Pain and Distress in Children and Teens During Needle Procedures
Longitudinal Multi-center Study on Neuropathic Pain and Brain Function in Adults
PATH-Pain Psychosocial Therapy to Improve Thinking and Depression in Older Adults with Mild Cognitive Impairment and Early Alzheimers Disease
Study of Live and Recorded Music Effects on Stress, Mood, Pain, and Biomarkers in Neurosurgery Patients
Randomized Study of Cebranopadol to Reduce Opioid Withdrawal Symptoms in Adults with Chronic Pain
Phase 2 Study of Enalapril for Adults Aged 18 to 70 With Painful Venous Malformations to Reduce Pain and Improve Quality of Life
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Impact of PerioperAtive LidocAine Infusions on Enhanced Recovery After Noncardiac Surgery (IMPALA-ERAS) in an inpatient setting: rationale, design and protocol for a sequential, repeated crossover trial.
Gerald W Rouleau, Aden W Smith, Crystal G Parrish...